Andrew E. Mulberg, Lisa L. Mathis, Dianne Murphy, Julia Dunne
Pediatric Drug Development, Second Edition, encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and other novel aspects of pediatric drug development.
Product Details
- Hardcover: 624 pages
- Publisher: Wiley-Blackwell; 2 edition (August 19, 2013)
- Language: English
- ISBN-10: 1118312155
- ISBN-13: 978-1118312155
Reviews
There are no reviews yet.